290 related articles for article (PubMed ID: 7680144)
1. Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients.
Stephens J; Goldstein R; Crippin J; Husberg B; Holman M; Gonwa TA; Klintmalm G
Transplant Proc; 1993 Feb; 25(1 Pt 2):1122-3. PubMed ID: 7680144
[No Abstract] [Full Text] [Related]
2. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
Dé P; Bechstein WO; Blumhardt G; Lange D; Schattenfroh N; Neuhaus P
Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279
[No Abstract] [Full Text] [Related]
3. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.
Papatheodoridis GV; Hamilton M; Mistry PK; Davidson B; Rolles K; Burroughs AK
Gut; 1998 Nov; 43(5):639-44. PubMed ID: 9824344
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppression is not related to the response to steroids in acute liver rejection.
Bercedo J; Jiménez C; Moreno E; García MA; Palomo JC; Loinaz C; Marcello M; Moreno C; Chamorro A; Manzanera M
Transplant Proc; 1995 Aug; 27(4):2328-9. PubMed ID: 7652830
[No Abstract] [Full Text] [Related]
5. Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children.
Lee WS; Karthik SV; Ng RT; Ong SY; Ong C; Chiou FK; Wong SY; Quak SH; Aw MM
Pediatr Neonatol; 2019 Aug; 60(4):396-404. PubMed ID: 31409456
[TBL] [Abstract][Full Text] [Related]
6. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
Millis JM; Bruce DS; Newell KA; Piper JB; Woodle ES; Seaman DS; Baker AL; Hart J; Dasgupta K; Thistlethwaite JR
Transplant Proc; 1996 Apr; 28(2):1014. PubMed ID: 8623213
[No Abstract] [Full Text] [Related]
7. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
[No Abstract] [Full Text] [Related]
8. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation.
Lange D; Bechstein WO; Blumhardt G; Lemmens P; Schattenfroh N; Neuhaus P
Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207
[No Abstract] [Full Text] [Related]
9. Results of orthotopic liver-small bowel transplantation in the pig using different immunosuppressive regimens.
Rossi G; Gatti S; Reggiani P; Orsenigo R; Maggi U; Franco P; Marelli O; Perego C; Colledan M; Gridelli B; Quarenghi E; Di Mauro P; Doglia M; Fassati LR; Galmarini D
Transplant Proc; 1996 Oct; 28(5):2519-22. PubMed ID: 8907932
[No Abstract] [Full Text] [Related]
10. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.
Kugelmas M; Spiegelman P; Osgood MJ; Young DA; Trotter JF; Steinberg T; Wachs ME; Bak T; Kam I; Everson GT
Liver Transpl; 2003 Jul; 9(7):727-32. PubMed ID: 12827560
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
[TBL] [Abstract][Full Text] [Related]
12. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
[No Abstract] [Full Text] [Related]
13. [Interrelation between liver and bowel involvement in ulcerative colitis patients undergoing liver transplantation].
Ilan Y; Eid A; Sikuler I; Katz E; Shouval D; Tur-Kaspa R
Harefuah; 1993 Dec; 125(11):398-400, 448. PubMed ID: 8112662
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for sclerosing cholangitis.
Narumi S; Roberts JP; Emond JC; Lake J; Ascher NL
Hepatology; 1995 Aug; 22(2):451-7. PubMed ID: 7635412
[TBL] [Abstract][Full Text] [Related]
15. Rejection: FK 506 for rescue or maintenance.
Klintmalm GB; Gibbs JF; McMillan R; Backman L; Levy M; Goldstein RM; Husberg BS; Holman MJ; Gonwa TA
Transplant Proc; 1993 Apr; 25(2):1914-5. PubMed ID: 7682356
[No Abstract] [Full Text] [Related]
16. Cyclosporine levels in the early posttransplant period: predictive of chronic rejection in liver transplantation?
Soin AS; Rasmussen A; Jamieson NV; Tokat Y; Watson CJ; Friend PJ; Wight DG; Calne RY
Transplant Proc; 1995 Feb; 27(1):1129-30. PubMed ID: 7878821
[No Abstract] [Full Text] [Related]
17. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss.
Bahra M; Neumann UP; Jacob D; Langrehr JM; Neuhaus P
Transplant Proc; 2005 May; 37(4):1700-2. PubMed ID: 15919436
[TBL] [Abstract][Full Text] [Related]
18. Does initial graft function influence the outcome after liver transplantation?
Mueller AR; Platz KP; Krause P; Neuhaus R; Lobeck H; Neuhaus P
Transplant Proc; 1998 Jun; 30(4):1464-5. PubMed ID: 9636594
[No Abstract] [Full Text] [Related]
19. Idiopathic ulcerative colitis in patients with primary sclerosing colitis undergoing orthotopic liver transplantation (OLT).
Chalasani N; Smallwood G
Am J Gastroenterol; 1998 Mar; 93(3):481-2. PubMed ID: 9517670
[No Abstract] [Full Text] [Related]
20. FK506 for primary and rescue therapy following liver transplantation.
Platz KP; Mueller AR; Zytowski M; Lobeck H; Neuhaus P
Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
[No Abstract] [Full Text] [Related]
[Next] [New Search]
